Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AZN
AZN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AZN News
AstraZeneca Reports Positive COPD Trial Results
3d ago
NASDAQ.COM
AstraZeneca's Antibody Therapy Achieves Phase 3 Trial Success
3d ago
seekingalpha
First IL-33-Targeting Biologic Shows Significant Reduction in COPD Exacerbations
3d ago
Newsfilter
AstraZeneca and Sanofi Expand R&D Operations in China
Mar 20 2026
seekingalpha
Senhwa Biosciences Achieves Breakthrough in Photodynamic Therapy
Mar 17 2026
Yahoo Finance
Andrew Hamilton Acquires Omeprazole.com Domain
Mar 17 2026
Yahoo Finance
AstraZeneca and Daiichi Sankyo Secure US Priority Review for Enhertu
Mar 15 2026
Yahoo Finance
Analysis of Investment Opportunities in International Stocks
Mar 14 2026
Fool
International Stocks Trading at Significant Discounts Compared to U.S. Equities
Mar 14 2026
NASDAQ.COM
AstraZeneca Poised to Acquire Abivax Amid Surge in Valuation
Mar 12 2026
Benzinga
Joshua Jackson Partners with AstraZeneca to Promote Cancer Screening
Mar 10 2026
Newsfilter
AstraZeneca's Koselugo Approved in Canada
Mar 09 2026
NASDAQ.COM
ENHERTU Shows 53% Reduction in Recurrence Risk in Breast Cancer Trial
Mar 09 2026
Newsfilter
Daiichi Sankyo and AstraZeneca's ENHERTU Application Receives Priority Review
Mar 09 2026
NASDAQ.COM
ENHERTU Shows 53% Reduction in Breast Cancer Recurrence Risk in Phase 3 Trial
Mar 09 2026
Newsfilter
Xencor Lowers Outlook After Royalty Dispute
Mar 05 2026
seekingalpha
Show More News
